Similaridades clinicopatológicas entre paratuberculosis y enfermedad de Crohn. ¿Posible vínculo zoonótico?

Contenido principal del artículo

Autores

Johan Calderón Agustín Góngora

Resumen

EL artículo presenta a la luz de la literatura científica actual la asociación del Mycobacterium avium subespecie paratuberculosis con la enfermedad de Crohn, las principales similaridades clinicopatológicas. La revisión se limitó a las publicaciones contenidas en el programa HINARI de la WHO, en especial de Elservier Science, Bioline Internacional, Blackwell Publishing, BMJ Publishing, Lippincott Williams & Wilkins, Nature Publishing, PubMed, Springer Science y publicaciones de la Asociación Internacional para estudio de Paratuberculosis. Evidencias significativas apoyan un posible vinculo zoonótico entre las enfermedades. El aislamiento del Mycobacterium avium subespecie paratuberculosis en pacientes con enfermedad de Crohn desde muestras de intestino, leche, sangre periférica y nódulos linfáticos; de igual manera la respuesta inmune especifica a algunos antígenos de Mycobacterium en pacientes con la enfermedad; aunque estos hallazgos tienen cada uno sus propias controversias. La evidencia actualmente disponible no es suficiente para validar o negar al Mycobacterium avium subespecie paratuberculosis como agente causal de por lo menos algunos casos de enfermedad de Crohn. Los estudios son inconclusos en aceptar un vinculo zoonótico dada la naturaleza multifactorial de esta enfermedad. Se requieren estudios para determinar sí Mycobacterium es un agente espectador ó patogénico; paralelamente realizar estudios epidemiológicos a gran escala que permitan analizar la distribución geográfica y temporal de ambas enfermedades.

Palabras clave:

Detalles del artículo

Referencias

1 Clarke C. The pathology and pathogenesis of paratuberculosis in ruminants and other species. J Comp Pathol 1997;(116):217-261.

2 Bernstein C, Blanchard J. The epidemiology of Crohn's disease. Gastroenterol 1999; (116):1503-1506.

3 Hermon-taylor J, Bull T, Sheridan J, Cheng J, Stellakis M, Sumar N. Causation of Crohn's Disease by Mycobacterium avium subsp. paratuberculosis. Can J Gastroenterol 2000; (14):521-539.

4 Boelaert F, Walravens K, Biront P, Berkvens D. Prevalence of paratuberculosis (Johne's disease) in the Belgian cattle population. Vet Microbiol 2000; (77): 269-281.

5 Sung N, Collins M. Thermal tolerance of Mycobacterium paratuberculosis. Appl Environ Microbiol 1998; (64): 999-1005.

6 Lund B, Gould G, Rampling A. Pasteurization of milk and the heat resistance of Mycobacterium avium subsp. paratuberculosis: a critical review of the data. Int J Food Microbiol 2002; (77): 135-145.

7 Johne's Information Center. National Johne's Disease Control Program Strategic Plan. [En línea]. 2004; [Fecha de acceso Noviembre de 2006]. URL Disponible en: http://johnes.net/general/ control.html

8 Góngora A, Villamil L. La paratuberculosis bovina desde la óptica de la salud pública. Revista Holstein 1999; (24):44-48.

9 Greig A, Henderson V, Hughes V, Pavlik I, Sharp J. Epidemiological study of paratuberculosis in wild rabbits in Scotland. J Clin Microbiol 1999; 37(6): 1746-1751.

10 Biet F, Boschiroli M, Thorel M. Zoonotic aspects of Mycobacterium bovis and Mycobacterium avium-intracellulare complex (MAC). Vet Res 2005; 369: 411- 436. http://dx.doi.org/10.1051/vetres:2005001

11 Pavlik I, Dvorska L, Bartl J, Svastova P, Rychlik I. Standardisation of restriction fragment length polymorphism analysis for Mycobacterium avium subspecies paratuberculosis. J Microbiol Meth 1999; (38): 155-167.

12 Beran M, Havelkova J, Kaustova L, Dvorska I. Cell wall deficient forms of mycobacteria: a review. Vet Med 2006; 51(7): 365–389.

13 Marks D, Harbord M, MacAllister R, Rahman F. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 2006; 367: 668–678. http://dx.doi.org/10.1016/S0140-6736(06)68265-2

14 Rubery E. A review of the Evidence for a Link between Exposure to Mycobacterium paratuberculosis (MAP) and Crohn's disease (CD) in Humans. A report for the Food Standards Agency. [En línea]. 2002; 1-52. [Fecha de acceso Septiembre de 2006].URL Disponible en: http:// www.foodstandards.gov.uk

15 Streeter R, Hoffsis G, Rings M. Isolation of Mycobacterium paratuberculosis from colostrum and milk of subclinically infected cows. Am J Vet Res 1995; (56): 1322-1324.

16 European Commission. Possible links between Crohn's disease and Paratuberculosis. Report of the Scientific Committee on Animal Health and Animal Welfare. [En línea]. 2000; 1- 76. [Fecha de acceso Septiembre de 2006]. URL Disponible en: http:// europa.eu.int/comm/health/sc/scah

17 ICA; Instituto Colombiano Agropecuario. Boletín epidemiológico animal. [En línea]. 2005. [Fecha de acceso Noviembre de 2006]. URL Disponible en: http:// www.ica.gov.co

18 APHIS; Animal and Plant Health Inspection Service. Uniform Program Standards for the Voluntary Bovine Johne's Disease Control Program. United States Department of Agricultura 2006; 1-40.

19 Chamberlin W, Naser A. Integrating theories of the etiology of Crohn's Disease On the etiology of Crohn's Disease: Questioning the Hypotheses. Med Sci Monit 2006; 12(2): 27-33.

20 Bayless T. Crohn's Disease: Concordance for site and clinical type in affected familiy members - hereditary influences. Gastroenterol 1996; (111): 573-579.

21 Hugot J, Zouali H, Lesage S, Almer S, Thomas G. Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature 2001; (411):599-603.

22 Ogura Y, Bonen D, Inohara N. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603–606. http://dx.doi.org/10.1038/35079114

23 Behr M, Semret M, Poon A. Crohn's disease, mycobacteria, and NOD2. Lancet Infect Dis 2004; 4: 136-137. http://dx.doi.org/10.1016/S1473-3099(04)00935-1

24 Quirke J. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn´s disease: Antagonist. Gut 2001; (49):757-760.

25 FSANZ; Food Standards Australia New Zealand. Association between Johne's disease and Crohn's disease: A microbiological review. Technical report 35. [En línea]. 2004; 1-21. [Fecha de acceso Agosto de 2006]. Disponible en: http://www.foodstandards.gov.au

26 Lee J, Lennard-Jones J. Inflammatory Bowel Disease in 67 families each with three or more affected first-degree relatives. Gastroenterol 1996; (111): 587-596.

27 Sartor R. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997; (92): 5-11.

28 Powell J, Harvey R, Ashwood P. Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmun 2000; (14): 99-105.

29 Grant I. Zoonotic potencial of Mycobacterium paratuberculosis. Modern Perspectives Zoonoses 1997; (27): 75- 83.

30 Macdermott R, Sanderson I, Reinecker H. The central role of chemotactic cytokines in the immuno-pathogenesis of ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 1998; (4): 54-67.

31 Goswami T, Joardar S, Ram G, Singh D. Association of Mycobacterium paratuberculosis in Crohn's disease and Johne's disease: A possible zoonotic threat. Curr Sci 2000; (79): 1076-1081.

32 Greenstein RJ. Is Crohn's disease caused by a mycobacterium; Comparisons with leprosy, tuberculosis and Johne's disease. Lancet Infect Dis 2003; 3(8):507-514. http://dx.doi.org/10.1016/S1473-3099(03)00724-2

33 Instituto Nacional de Salud. Comunicación personal. Contacto Web INS Antonio José Bermúdez Fernández. [En línea]. 2006. [Fecha de acceso Septiembre 13 de 2006]. URL Disponible en: http://www.ins.gov.co/ / portal_ins@ins.gov.co

34 WHO; World Health Organization. Extrapolated Prevalence of Crohn's Disease on Americas and the World. US Census bureau, International Data Base. [En línea]. 2004. [Fecha de acceso Octubre de 2006].URL Disponible en: http://www.who.org.int

35 Van kruiningen H. Lack of support for a common etiology in Johne´s disease of animals and Crohn disease in humans. Inflamm Bowel Dis 1999; (5): 183-191.

36 Chiodini R, Van Kruiningen H, Thayer W. Possible role of Mycobacteria in inflammatory bowel diseases. An unclassified Mycobacterium species isolated from patients with Crohn's disease. Dig Disord Sci 1984; (29): 1073- 1079.

37 Naser S, Schwartz D, Shafran I. Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's Disease Patients. Am J Gastroenterol 2000; (95): 1094-1095.

38 Hermon-Taylor J, Barnes N, Clarke C, Finlayson C. Grand Round Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar Crohn's Disease. Br Med J 1998; (316): 449-453.

39 Chamberlin W, Graham D, Hulten K. Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. Aliment Pharmacol 2001; (15): 337-346.

40 Naser S, Ghobrial G, Romero C, Valentine J. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 2004; (364): 1039–1044.

41 Bull T, Skull A, Durkin D, Neild P, Rhodes G, Pickup R. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J Clin Microbiol 2003; 41(7): 2915-2923. http://dx.doi.org/10.1128/JCM.41.7.2915-2923.2003

42 El-Zaatari F, Naser S, Hulten K, Burch P, Graham D. Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease. Curr Microbiol 1999; (39): 115- 119.

43 Naser S, Hulten K, Shafran I, Graham D, El-Zaatari F. Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M.avium subsp. paratuberculosis. Vet Microbiol 2000; (77):497-504.

44 Suenaga K, Nishimori I, Sano S, Morita M, Okazaki K. Serum antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. Dig Dis Sci 1999; (44):1202-1207.

45 Thomas G, Swift G, Green J, Rhodes J, Wilkinson S. Controlled trial of antituberculous chemotherapy in Crohn´s disease: A five years follow up study. Gut 1998; (42):497-500.

46 Gui G, Thomas P, Tizard M, Lake J, Hermon-Taylor J. Two years outcomes analisys of Crohn´s disease treated with rifabutin and macrolide antibiotics. J Antimicrob Chemother 1997; (9):393-400.

47 Borgaonkar M, Maclntosh D, Fardy J. A meta-analysis of antimycobacterial therapy does not increase the rate of maintenance of remission in Crohn's disease. Am J Gastroenterol 2000; (95):725-729.

48 Mishina D, Katsel P, Brown S, Gilberts E, Greenstein R. On the etiology of Crohn disease. Proc Nat Acad Sci USA 1996; (93): 9816-9820.

49 Keswani J, Frank J. Thermal inactivation of Mycobacterium paratuberculosis in milk. J Food Protect 1998; (61): 974- 978.

50 Van Kruiningen H, Chiodini R, Thayer W. Experimental disease in infant goats induced by a Mycobacterium isolated from a patient with Crohn's Disease. Dig Dis Sci 1986; (31): 1351-1360.

Descargas

La descarga de datos todavía no está disponible.